HOME AND AMBULATORY BLOOD PRESSURE MONITORING

Similar documents
ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

The Hypertension Treatment Center

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Measurement of Blood Pressure

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Cardiovascular Risk in Diabetes

From Concept to Rapid Visualization a Data Analytics Case Study

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

MEDICAL POLICY No R4 BLOOD PRESSURE MONITORS & AMBULATORY BLOOD PRESSURE MONITORING

Plank 1 Tool: Hypertension Medical Assistant Training (Providence Medical Group)

Corporate Medical Policy Ambulatory Blood Pressure Monitoring

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Hypertension Guideline V4

Device Equivalence Evaluation Form

How to measure blood pressure using digital monitors

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8)

CDS Starter Kit: Diabetes f ollow-up care

Blood pressure pattern and heart rate variability in normotensive patients with type 2

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost

HIGH BLOOD PRESSURE AND YOUR KIDNEYS

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Let s Do It Well. Nurse Learning Pack

MEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY BLOOD PRESSURE MONITORING

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines

Chronic Daily Headache and Blood Pressure Interrelated Prognosis

Guidelines for the management of hypertension in patients with diabetes mellitus

Telemedicine in Prevention and Chronic Disease Management

Pharmacy and the Medicaid Accountable Care Organization

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Vascular Risk Reduction: Addressing Vascular Risk

a Centre de Médecine Cardiovasculaire, Paris, France and b Lebanese Received 7 June 2009 Revised 6 September 2009 Accepted 17 September 2009

Background of the study

Drug treatment of elevated blood pressure

Blood Pressure. Blood Pressure (mm Hg) pressure exerted by blood against arterial walls. Blood Pressure. Blood Pressure

Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, ESRD Registry Committee, Korean Society of Nephrology*

SUMMARY OF CHANGES TO QOF 2015/16 - ENGLAND CLINICAL

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD

Population Health Management

Device Equivalence Evaluation Form

Barostimulaatio ja renaalinen denervaatio

CHEM 1406 BSA/BMI Measurement Laboratory (revised 01/03//06) BSA, Body Surface Area

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration

Blood Pressure Assessment Program Screening Guidelines

Case Study 6: Management of Hypertension

AHA/ASH/PCNA Scientific Statement

Hypertension and Diabetes

The minimum numbers required for each blood pressure group.

The Cross-Sectional Study:

Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1

24-hour blood pressure monitoring: its efficacy and techniques

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

HYPERTENSION MANAGEMENT AND SURVEILLANCE AT PRIMARY CARE LEVEL: A SITUATIONAL ANALYSIS IN THE LIMPOPO PROVINCE

Disclosure of Relationships

Vasc Health Risk Manag. 2011; 7: Published online 2011 November 30. doi: /VHRM.S27193 PMCID: PMC

Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

Understanding diabetes Do the recent trials help?

Hypertension Guidelines

Barry P McGrath, and on behalf of the National Blood Pressure Advisory Committee of the National Heart Foundation of Australia

Hypertension and Diabetes Status Bangladesh Demographic and Health Survey

Device Equivalence Evaluation Form

Hypertension Best Practices Symposium

9/19/2013. Standardizing Preventive Care for Hypertension. About the Speaker. About the Speaker

Ambulatory blood pressure monitoring

UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient

Absolute cardiovascular disease risk assessment

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine

Diabetic Nephropathy

ENGAGING PHARMACISTS IN 1305

Treatment of Hypertension: JNC 8 and More

Hypertension. Clinical management of primary hypertension in adults. This guideline partially updates and replaces NICE clinical guideline 34

Absolute cardiovascular disease risk

High Blood Pressure and Your Kidneys

AMBULATORY BLOOD PRESSURE MONITORING QUICK START GUIDE

Hypertension Diagnosis and Treatment

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한

PAYMENT INNOVATIONS SUPPORTING BEHAVIORAL HEALTHCARE DELIVERY IMPROVEMENT. NGA July 2015

Medical Statistics, School of Medicine, University of Athens, Greece

mhealth Programs Designed by Patients & Providers for Chronic Disease Management

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks

Tips and tricks in hypertension

How To Improve Care At Geisinger

September 6, Dear Administrator Tavenner:

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Epidemiology of Hypertension 陈 奕 希 李 禾 园 王 卓

Geriatric Cardiology: Challenges and Strategies

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Hai Fang, PhD Professor China Center for Health Development Studies Peking University

BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

Supplementary Online Content

MIND-BODY THERAPIES FOR HYPERTENSION

Obstructive sleep apnea and type 2 diabetes Obstructive Sleep Apnea (OSA) may contribute to or exacerbate type 2 diabetes for some of your patients.

Section 8: Clinical Exercise Testing. a maximal GXT?

Special Communication

Correspondence to: Rima B Shah (rima_1223@yahoo.co.in) DOI: /ijmsph Received Date: Accepted Date:

Transcription:

HOME AND AMBULATORY BLOOD PRESSURE MONITORING 1

2

Uses of ABPM and Home BPM Diagnosis of Hypertension Diagnosis of White Coat Hypertension Diagnosis of Masked Hypertension Assessment of prognostically important asleep and early morning blood pressures Monitoring efficacy of treatment 3

Diagnostic algorithm for high Blood Pressure including Office, ABPM and Home Blood Pressure Measurement Elevated Out of the Office BP measurement Hypertension Visit 2 within 1 month Hypertension Visit 1 BP Measurement, History and Physical examination Diagnostic tests ordering at visit 1 or 2 BP 140/90 mmhg and Target organ damage or Diabetes or Chronic Kidney Disease or BP 180/110? Elevated Random Office BP Measurement Yes Hypertensive Urgency / Emergency Diagnosis of HTN No BP: 140-179 / 90-109 4

Diagnostic algorithm for high Blood Pressure including Office, ABPM and Home Blood Pressure Measurement Hypertension Visit 1 BP Measurement, History and Physical examination Hypertensive Urgency / Emergency Hypertension Visit 2 Target Organ Damage or Diabetes or Chronic Kidney Disease or BP 180/110? Yes Diagnosis of HTN No BP: 140-179 / 90-109 Clinic BPM ABPM (If available) HBPM 5

Diagnostic algorithm for high Blood Pressure including Office, ABPM and Home Blood Pressure Measurement BP: 140-179 / 90-109 Clinic BP Hypertension visit 3 160 SBP or 100 DBP < 160 / 100 or Hypertension visit 4-5 Diagnosis of HTN ABPM or HBPM Awake BP < 135/85 and 24-hour < 130/80 ABPM (If available) Awake BP 135 SBP or 85 DBP Or 24-hour 130 SBP or 80 DBP < 135/85 or HBPM 135 SBP or DBP 85 140 SBP or 90 DBP Diagnosis of HTN Continue to follow-up Diagnosis of HTN Continue to follow-up Diagnosis of HTN < 140 / 90 Continue to follow-up 6

Normal Values Office BP < 140 / 90 (< 130/80 for DM, CKD, TOD) ABPM awake average < 135/85 (125/75 for DM, CKD, TOD) ABPM asleep average < 120/70 Home BPM average < 135/85 (125/75 for DM, CKD, TOD) 7

The concept of masked hypertension Home or daytime ABPM SBP mmhg 135 Masked HTN True Normotensive 140 True hypertensive White Coat HTN 135 140 Office SBP mmhg From Pickering, Hypertension 1992 8

The prognosis of masked hypertension Prevalence of masked hypertension is approximately 10% in the general population (prevalence is higher in diabetic patients). 2.5 2 Relatve risk of CVD 1.5 1 0.5 0 Normotension White Coat Hypertension Masked Hypertension Hypertension J Hypertension 2007;25:2193-98 9

Threshold for Initiation of Treatment and Target Values Condition Diastolic ± systolic hypertension Isolated systolic hypertension Home BP measurement (no diabetes, renal disease or proteinuria) Diabetes or chronic kidney disease Initiation SBP / DBP mmhg 140/90 SBP >160 ( 135/85) 130/80 Target SBP / DBP mmhg <140/90 <140 <135/85 <130/80 10

Home measurement of blood pressure Home BP measurement should be encouraged to increase patient involvement in care Which patients? For the diagnosis of hypertension Suspected non adherence White coat hypertension or effect Masked hypertension Average BP equal to or over 135/85 mmhg should be considered elevated 11

Benefits of Home Blood Pressure Monitoring Rapid confirmation of the diagnosis of hypertension Better prediction of cardiovascular prognosis Diagnosis of white coat and masked hypertension Reduced medication use in white coat effect Improved adherence to drug therapy Better blood pressure 12

Not all patients are suited to home measurement Undue anxiety in response to high blood pressure readings Physical or mental disability prevents accurate technique or recording Arm not suited to blood pressure cuff (e.g. conical shaped arm) Irregular pulse or arrhythmias prevent accurate readings Lack of interest The vast majority of patients can be trained to measure blood pressure 13

Suggested Protocol for Home Measurement of Blood Pressure for the diagnosis of hypertension Home blood pressure values should be based on: - duplicate measures, - morning and evening, - for an initial 7-day period. Singular and first day home BP values should not be considered. Daytime average BP equal to or over 135/85 mmhg should be considered elevated 14

Home Measurement of BP: Patient Education How to? Use devices: appropriate for the individual appropriate cuff size validated device Adequate patient training in: measuring their BP interpreting these readings Values > 135 / 85 mmhg should be considered elevated Home measurement can help to improve patient adherence Regular verification measuring techniques 15

Suggested Protocol for Home Measurement of Blood Pressure How? Home blood pressure values for assessing white coat hypertension or sustained hypertension should be based on: Duplicate measures, Morning and evening, For an initial 7-day period. Single readings and First day home BP values should not be considered. For patients treated for hypertension Morning measurement should be done before medication taking 16

Home Measurement of BP: Patient Education Assist patients select a model with the correct size of cuff Measure and record the patients mid arm circumference so they can match it to cuff size Recommend devices validated by British Hypertension Society Ask patients to carefully follow the instructions with device and to record only those blood pressure readings where they have followed recommended procedure Advise patients that average readings equal to or over 135/85 mmhg are high a lower threshold is appropriate for those with diabetes or chronic kidney disease Values equal to or over 135 / 85 mmhg should be considered elevated for those without diabetes or chronic kidney disease Home measurement can help to improve patient adherence 17

Which monitor to recommend to patients? British Hypertension Society maintains an updated list of validated home BP monitors http://www.bhsoc.org/bp_monitors/automatic.stm (or Google British Hypertension Society and click on Blood pressure Monitors ) 18

Suggested use of ABPM AND Home BPM in the Management of Hypertension Office BP > 140/90 mmhg in low risk patients (with no target-organ disease) Home-monitored blood pressure <135/85mmHg Home-monitored blood pressure equals or over 135/85mmHg Perform ABPM Mean awake BP Less than 135/85 mmhg Mean awake BP equals or over 135/85 mmhg Follow-up with periodic home- BP measurement and or repeated ABPM every 1-2yr. Initiate antihypertensive therapy ABPM: Ambulatory Blood Pressure Monitoring BP: Blood Pressure Adapted from White W, NEJM 348:24, June 12, 2003 19

Special Indications for ABPM (1) Suspect white coat hypertension 20% of individuals with office hypertension have normal profile on ABPM These people do not generally require drug therapy (although their risk is slightly higher than true normotensives) They have a higher risk of progression to establised hypertension and need to be followed long-term (may need eg annual ABPM) 20

(2) Masked Hypertension Office BP < 140/90 (or 130/80 in DM or CKD) with: awake average BP on ABPM >= 135/85 (125/75 in DM or CKD) or or 24 hour average BP on ABPM >= 130/80 (120/70 in DM or CKD) Suspect where target organ damage with normal office blood pressures Untreated associated with adverse prognosis. 21

(3) Assess Nocturnal Dip and Morning Surge Average asleep blood pressure should be at least 10% lower than average awake blood pressure ( nocturnal dip ) Non-dipper status associated with adverse cardiovascular prognosis (common is states of sympathetic overactivity eg diabetes and CKD) Highest blood pressures usually in the early morning (6-10am) highest risk time for MI and stroke. Exaggerated surge (> 160/100) is a significant risk factor even when average blood pressure adequately controlled. (NB many 24-hour antihypertensive meds are wearing off at the time of highest risk) Both non-dipping and morning surge can be addressed by apropriately timed adjustment to meds use drugs know to have long ½ lives evening or bedtime dosing or 1 or more drugs (or even 3am if getting up to PU at that time). 22

(4) Assess Efficacy of Treatment Some treated hypertensives have an office white coat effect and appear to be resistant to increasing therapy - these individuals may need serial ABPM to monitor the effect of therapy. Home BP monitoring is also useful in these individuals 23

CONCLUSION: Ambulatory and Home Blood Pressure Monitoring are now an integral (evidence-based) part of hypertension management and should be widely used. 24